Everence Capital Management Inc. Trims Stake in Integer Holdings Co. (NYSE:ITGR)

Everence Capital Management Inc. lessened its position in shares of Integer Holdings Co. (NYSE:ITGR) by 25.7% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 3,090 shares of the medical equipment provider’s stock after selling 1,070 shares during the quarter. Everence Capital Management Inc.’s holdings in Integer were worth $409,000 as of its most recent SEC filing.

Several other institutional investors also recently added to or reduced their stakes in ITGR. Earnest Partners LLC increased its holdings in shares of Integer by 3.2% in the second quarter. Earnest Partners LLC now owns 1,208,319 shares of the medical equipment provider’s stock valued at $139,911,000 after purchasing an additional 37,340 shares during the period. Geode Capital Management LLC raised its stake in shares of Integer by 1.2% during the 3rd quarter. Geode Capital Management LLC now owns 764,528 shares of the medical equipment provider’s stock worth $99,408,000 after buying an additional 9,421 shares during the last quarter. Loomis Sayles & Co. L P raised its position in Integer by 3.0% during the third quarter. Loomis Sayles & Co. L P now owns 538,027 shares of the medical equipment provider’s stock worth $69,943,000 after acquiring an additional 15,446 shares during the last quarter. Congress Asset Management Co. lifted its stake in Integer by 3.9% in the 3rd quarter. Congress Asset Management Co. now owns 488,785 shares of the medical equipment provider’s stock valued at $63,542,000 after buying an additional 18,303 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its position in shares of Integer by 1.2% in the third quarter. Charles Schwab Investment Management Inc. now owns 404,029 shares of the medical equipment provider’s stock valued at $52,524,000 after acquiring an additional 4,946 shares in the last quarter. Institutional investors and hedge funds own 99.29% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on the stock. Piper Sandler reiterated an “overweight” rating and set a $140.00 price objective (up from $125.00) on shares of Integer in a report on Friday, October 25th. Truist Financial raised their price objective on shares of Integer from $147.00 to $163.00 and gave the stock a “buy” rating in a report on Wednesday, December 11th. KeyCorp increased their price objective on shares of Integer from $139.00 to $144.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 15th. Citigroup upped their target price on shares of Integer from $130.00 to $145.00 and gave the stock a “neutral” rating in a research report on Wednesday, December 11th. Finally, Bank of America raised their target price on shares of Integer from $135.00 to $145.00 and gave the company a “buy” rating in a research note on Tuesday, October 1st. One equities research analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $145.44.

Integer Stock Up 1.3 %

Shares of NYSE ITGR opened at $133.89 on Monday. Integer Holdings Co. has a 52-week low of $94.56 and a 52-week high of $142.76. The company has a debt-to-equity ratio of 0.67, a quick ratio of 2.09 and a current ratio of 3.28. The business has a fifty day moving average of $135.34 and a two-hundred day moving average of $127.32. The stock has a market cap of $4.49 billion, a PE ratio of 41.32, a PEG ratio of 1.99 and a beta of 1.12.

Integer (NYSE:ITGR) last released its quarterly earnings results on Thursday, October 24th. The medical equipment provider reported $1.43 earnings per share for the quarter, beating analysts’ consensus estimates of $1.36 by $0.07. The firm had revenue of $431.42 million during the quarter, compared to analysts’ expectations of $440.59 million. Integer had a return on equity of 11.63% and a net margin of 6.70%. The business’s revenue was up 8.7% on a year-over-year basis. During the same period last year, the firm posted $1.27 EPS. As a group, equities research analysts expect that Integer Holdings Co. will post 5.33 earnings per share for the current fiscal year.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.